Antonio
Gómez Caamaño
Complexo Hospitalario Universitario de Santiago
Santiago de Compostela, EspañaPublicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (75)
2023
-
Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants
Nature Genetics, Vol. 55, Núm. 12, pp. 2065-2074
-
Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study
Radiotherapy and Oncology, Vol. 178
-
Large-scale meta-genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types
JNCI Cancer Spectrum, Vol. 7, Núm. 6
-
Radiobiological Meta-Analysis of the Response of Prostate Cancer to Different Fractionations: Evaluation of the Linear–Quadratic Response at Large Doses and the Effect of Risk and ADT
Cancers, Vol. 15, Núm. 14
-
Radiogenomics in lung cancer: Where are we?
Lung Cancer, Vol. 176, pp. 56-74
-
Variation of the relative biological effectiveness with fractionation in proton therapy: Analysis of prostate cancer response
Medical Physics, Vol. 50, Núm. 11, pp. 7304-7312
2022
-
Development of castration resistance in prostate cancer patients treated with luteinizing hormone-releasing hormone analogues (LHRHa): results of the ANARESISTANCE study
World Journal of Urology, Vol. 40, Núm. 10, pp. 2459-2466
-
Effect of LHRH analogs on lower urinary tract symptoms associated with advanced prostate cancer in real clinical practice: ANALUTS study
Neurourology and Urodynamics, Vol. 41, Núm. 8, pp. 1824-1833
-
High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer
Frontiers in Oncology, Vol. 12
-
Meta-GWAS identifies the heritability of acute radiation-induced toxicities in head and neck cancer
Radiotherapy and Oncology, Vol. 176, pp. 138-148
-
No Association Between Polygenic Risk Scores for Cancer and Development of Radiation Therapy Toxicity
International Journal of Radiation Oncology Biology Physics, Vol. 114, Núm. 3, pp. 494-501
-
Quality indicators and excellence requirements for a multidisciplinary lung cancer tumor board by the Spanish Lung Cancer Group
Clinical and Translational Oncology, Vol. 24, Núm. 3, pp. 446-459
-
RENORT: a project to analyze patterns of care in radiation oncology in Spain
Clinical and Translational Oncology, Vol. 24, Núm. 7, pp. 1322-1332
-
Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort
eBioMedicine, Vol. 84
-
Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer
Radiotherapy and Oncology, Vol. 168, pp. 75-82
2021
-
Evaluation of indirect damage and damage saturation effects in dose–response curves of hypofractionated radiotherapy of early-stage NSCLC and brain metastases
Radiotherapy and Oncology, Vol. 161, pp. 1-8
-
Health-related quality of life in men with localized prostate cancer treated with radiotherapy: validation of an abbreviated version of the Expanded Prostate Cancer Index Composite for Clinical Practice in Spain
Health and Quality of Life Outcomes, Vol. 19, Núm. 1
-
Management of localized muscle-invasive bladder cancer from a multidisciplinary perspective: Current position of the Spanish oncology genitourinary (Sogug)working group
Current Oncology, Vol. 28, Núm. 6, pp. 5084-5100
-
Palliative radiotherapy in CRC
Foundations of Colorectal Cancer (Elsevier), pp. 429-433
-
Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (Nature Genetics, (2021), 53, 1, (65-75), 10.1038/s41588-020-00748-0)
Nature Genetics